-
Cambrex: An Undervalued Stock
Post on 3/8/17
-
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis
Post on 3/8/17
-
3 Biotech Stocks You Don't Have to Babysit
Post on 3/8/17
-
House Republicans Take an Axe to the Obamacare Mandate
Post on 3/8/17
-
Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million
Post on 3/8/17
-
Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
Post on 3/7/17
-
ExpressCare Opens 30th Urgent Care Facility With Newest Location In Mt. Airy Section Of Carroll County, Maryland
Post on 3/7/17
-
Why Celldex Therapeutics Stock Gained 10% in February
Post on 3/7/17
-
Here's Why Pfizer Rallied 7.7% in February
Post on 3/6/17
-
Billionaires Love These 3 Healthcare Stocks
Post on 3/6/17
-
Safeguard Scientifics' (SFE) CEO Steve Zarrilli on Q4 2016 Results - Earnings Call Transcript
Post on 3/3/17
-
4 Reasons Johnson & Johnson Surged 8% in February
Post on 3/3/17
-
Merk: The Keytruda Success Story
Post on 3/3/17
-
Why Celgene's Shares Rallied Higher in February
Post on 3/3/17
-
Micro Interventional Device Wins CRT 2017's "Top Cardiovascular Innovation Award"
Post on 3/2/17
-
Integral Molecular and Integrated BioTherapeutics Initiate Collaboration
Post on 3/2/17
-
Medical Guardian Chosen as "Best Overall Company" in Medical Alerts Industry by BestCompany.com
Post on 3/2/17
-
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
Post on 3/2/17
-
Better Buy: Johnson & Johnson vs. AbbVie
Post on 3/2/17
-
Medical Oncology Hematology Consultants Joins The US Oncology Network
Post on 3/1/17
-
Philadelphia Research Consortium Launched to Speed Access to Preclinical Research Capabilities Across Philadelphia’s Life Sciences Community
Post on 3/1/17
-
Pfizer Stock History: How the Drugmaker Became an Industry Giant
Post on 3/1/17
-
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc
Post on 3/1/17
-
Blackfynn And CHOP Extend, Expand Partnership On Pediatric Cancer Research
Post on 2/28/17
-
Alliqua BioMedical Closes $2.8M Private Placement
Post on 2/28/17
Philadelphia
